H.C. Wainwright Reiterates Buy Rating on Intellia Therapeutics (NTLA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq hits record high as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: NTLA) | Delayed: 12.79 +0.53 (4.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.26 | 52 Week High | $30.40 | |||
| Open | $12.35 | 52 Week Low | $11.86 | |||
| Day High | $12.84 | P/E | N/A | |||
| Day Low | $11.85 | EPS | $0.00 | |||
| Volume | 3,314,128 | |||||
